| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |